Lexapro

— THERAPEUTIC CATEGORIES —
  • Anxiety/OCD
  • Mood disorders

Lexapro Generic Name & Formulations

General Description

Escitalopram (as oxalate) (single-isomer citalopram) 5mg, 10mg+, 20mg+; tabs (+scored).

Pharmacological Class

SSRI.

How Supplied

Tabs—100; Soln—contact supplier

Manufacturer

Mechanism of Action

The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the CNS resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).

Lexapro Indications

Indications

Generalized anxiety disorder.

Lexapro Dosage and Administration

Adult

Initially 10mg once daily; may increase to max 20mg once daily at an interval of no less than 1 week. Elderly or hepatic impairment: 10mg once daily.

Children

<7yrs: not established. Initially 10mg once daily; may increase to max 20mg once daily at an interval of no less than 2 weeks. Hepatic impairment: 10mg once daily.

Lexapro Contraindications

Contraindications

During or within 14 days of MAOIs; do not start an MAOI during or within 14 days of escitalopram. Concomitant pimozide, linezolid, IV methylene blue.

Lexapro Boxed Warnings

Boxed Warning

Suicidality and antidepressant drugs.

Lexapro Warnings/Precautions

Warnings/Precautions

Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; monitor for clinical worsening and unusual changes. History of seizures or mania/hypomania. Monitor for serotonin syndrome; discontinue if occurs. Hepatic impairment: see Adult and Children Dosage. Renal impairment (CrCl <20mL/min): not studied. Angle-closure glaucoma. Conditions that affect metabolic or hemodynamic responses. Recent MI. Unstable heart disease. Volume-depleted. Hyponatremia (esp. elderly). Sexual dysfunction. Avoid abrupt cessation. Reevaluate periodically. Write ℞ for smallest practical amount. Elderly. Labor & delivery. Pregnancy (during 3rd trimester; see full labeling for effects on neonate). Nursing mothers: monitor.

Lexapro Pharmacokinetics

Absorption

Absolute bioavailability: ~80%.

Peak blood levels occur at ~5 hours.

Distribution

Volume of distribution: ~12 L/kg.

Plasma protein bound: ~56%.

Metabolism

Hepatic (CYP3A4, CYP2C19).

Elimination

Half-life: ~27–32 hours.

Oral clearance: 600 mL/min.

Lexapro Interactions

Interactions

See Contraindications. Do not give with citalopram. Increased risk of serotonin syndrome with other serotonergic drugs (eg, SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, St. John's Wort) or with drugs that impair serotonin metabolism (eg, MAOIs, linezolid, IV methylene blue). Avoid alcohol. Increased risk of bleeding with concomitant NSAIDs, aspirin, warfarin, and others that affect coagulation. May be antagonized by carbamazepine. Caution with drugs metabolized by CYP2D6 or other centrally-acting drugs. Increases metoprolol levels.

Lexapro Adverse Reactions

Adverse Reactions

Insomnia, ejaculation disorder, nausea, increased sweating, fatigue, somnolence, decreased libido, anorgasmia.

Lexapro Clinical Trials

See Literature

Lexapro Note

Not Applicable

Lexapro Patient Counseling

See Literature

Lexapro Generic Name & Formulations

General Description

Escitalopram (as oxalate) (single-isomer citalopram) 5mg, 10mg+, 20mg+; tabs (+scored).

Pharmacological Class

SSRI.

How Supplied

Tabs—100; Soln—contact supplier

Manufacturer

Mechanism of Action

The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the CNS resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).

Lexapro Indications

Indications

Major depressive disorder (MDD).

Lexapro Dosage and Administration

Adult

Initially 10mg once daily; may increase to max 20mg once daily at an interval of no less than 1 week. Elderly or hepatic impairment: 10mg once daily.

Children

<12yrs: not established. 12–17yrs: initially 10mg once daily; may increase to 20mg once daily after 3 weeks.

Lexapro Contraindications

Contraindications

During or within 14 days of MAOIs; do not start an MAOI during or within 14 days of escitalopram. Concomitant pimozide, linezolid, IV methylene blue.

Lexapro Boxed Warnings

Boxed Warning

Suicidality and antidepressant drugs.

Lexapro Warnings/Precautions

Warnings/Precautions

Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; monitor for clinical worsening and unusual changes. History of seizures or mania/hypomania. Monitor for serotonin syndrome; discontinue if occurs. Hepatic impairment: see Adult and Children Dosage. Renal impairment (CrCl <20mL/min): not studied. Angle-closure glaucoma. Conditions that affect metabolic or hemodynamic responses. Recent MI. Unstable heart disease. Volume-depleted. Hyponatremia (esp. elderly). Sexual dysfunction. Avoid abrupt cessation. Reevaluate periodically. Write ℞ for smallest practical amount. Elderly. Labor & delivery. Pregnancy (during 3rd trimester; see full labeling for effects on neonate). Nursing mothers: monitor.

Lexapro Pharmacokinetics

Absorption

Absolute bioavailability: ~80%.

Peak blood levels occur at ~5 hours.

Distribution

Volume of distribution: ~12 L/kg.

Plasma protein bound: ~56%.

Metabolism

Hepatic (CYP3A4, CYP2C19).

Elimination

Half-life: ~27–32 hours.

Oral clearance: 600 mL/min.

Lexapro Interactions

Interactions

See Contraindications. Do not give with citalopram. Increased risk of serotonin syndrome with other serotonergic drugs (eg, SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, St. John's Wort) or with drugs that impair serotonin metabolism (eg, MAOIs, linezolid, IV methylene blue). Avoid alcohol. Increased risk of bleeding with concomitant NSAIDs, aspirin, warfarin, and others that affect coagulation. May be antagonized by carbamazepine. Caution with drugs metabolized by CYP2D6 or other centrally-acting drugs. Increases metoprolol levels.

Lexapro Adverse Reactions

Adverse Reactions

Insomnia, ejaculation disorder, nausea, increased sweating, fatigue, somnolence, decreased libido, anorgasmia.

Lexapro Clinical Trials

See Literature

Lexapro Note

Not Applicable

Lexapro Patient Counseling

See Literature

Images